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ABSTRACT 
Objective: Chlorpheneramine maleate is a first-generation antihistamine drug used in the treatment of allergic conditions like rhinitis, urticaria, 
and cough cold, etc. In present work, the challenge has been made to develop an orally disintegrating tablet of chlorpheneramine maleate with an 
increase in bioavailability and patient compliance. 
Methods: The sublimation technique was used to prepare orally disintegrating tablets. Porous tablet prepared after sublimation of camphor at 60 
°C in a hot air oven for 60 min. In the research work, 32 full factorial design used to find out the effect of two variables like the amount of 
Crospovidone and Croscarmellose sodium. 
Results: All prepared formulations were analyzed for various parameters. DSC of pure drug and optimized formulation A (9) showed purity of sample and 
compatibility of all ingredients with each other. In FTIR study of pure drug and optimized formulation A (9) no major shifts were seen. An optimized 
formulation (A9) was found to have good hardness (3.2 kg/cm2), friability (<1 %), disintegration time (26 s), % drug release (99.77 %) within 6 min. 
Conclusion: The result obtained showed that orally disintegrating tablet of chlorpheneramine maleate enhances dissolution rate, improves 
bioavailability which will improve patient compliance. 
Keywords: Chlorpheneramine maleate, Orally disintegrating tablet, Crospovidone, Croscarmellose sodium, Sublimation, Factorial design 




The drug can be delivered to the systemic circulation by various routes 
of administration but among them, the oral route of drug delivery is 
more common. Oral drug delivery provides advantages of self-
medication, ease of administration, harmless [1, 2]. Now a day’s efforts 
have been taken to ease of administration of the drug. In patients’ 
point of view, the orally disintegrating tablet is an attractive dosage 
form to all age patients [3]. The orally disintegrating tablet is a solid 
dosage form that gets easily disintegrate or dissolve when put on the 
tongue without the need for water. Many patients face problems in 
swallowing tablet dosage form, to overcome this problem tablets are 
made that easily disintegrate in saliva before swallowing. Orally 
disintegrating tablets provide benefits to pediatric and geriatric 
patients, patients who have a swallowing problem, traveling patients 
who are not able to maintain water all the time. Orally disintegrating 
tablets avoid the first-pass metabolism of the drug as absorption takes 
place through mouth, pharynx, and esophagus as saliva passes down 
into the stomach. In such cases, the bioavailability of the drug gets 
increases and improves patient compliance [4-6]. As the drug is easily 
disintegrating, the drug comes in contact with taste bud so taste 
masking of the drug can be done to improve good mouthfeel. The 
bitter drug should be administered after proper taste-masking to give 
good palatability [7-9]. Rapid onset of action, improvement in 
dissolution rate, accurate dosing, avoid suffocation due to physical 
obstruction, good mouthfeel, no need of water are the advantages of 
orally disintegrating tablets that increase acceptance criteria of the 
patient to use these dosage form. 
Chlorpheneramine maleate is a first-generation alkylamine 
antihistamines agent. The normal dose is about 4 mg every 4-6 h. 
Bioavailability is about 25-60 % with 70 % protein binding. Half-life is 
about 12-15 h. Desmethylchlorpheneramine and didesmethyl-
chlorpheneramine are the by-products of the metabolism of drug which 
lowers its bioavailability. It is used in the treatment of allergic conditions 
like rhinitis, urticaria, watery eyes, cough, and cold. It acts by binding to 
the H1 receptor and block the action of endogenous histamine, which 
respite symptoms of histamine. Common adverse effects are CNS 
depression, diarrhea, vomiting, dry mouth [10-12]. 
The aim of this work was to develop an orally disintegrating tablet 
by sublimation technique. The key to providing rapid disintegration 
of tablets by creating a porous structure in the tablet matrix. 
Camphor is used as a sublimating agent to develop pores after 
sublimation [13]. Crospovidone and Croscarmellose sodium are 
used as super disintegrant due to its capillary action [14-16]. 
Mannitol is used as the diluent and also useful in taste masking as it 
provides a good mouthfeel. Sodium saccharin and orange flavor are 
used as taste-masking agents [17]. 
MATERIALS AND METHODS 
Materials 
Chlorpheneramine maleate was obtained from (Yarrow chemicals 
Mumbai) and Crospovidone, Croscarmellose sodium (Vergo, Goa), 
Camphor, Sodium saccharin, Mannitol, Talc, Magnesium stearate, 
Orange flavor (Research lab, Fine chem. Industries, Mumbai.) 
Method 
Characterization of drug and excipients 
Differential scanning calorimetry (DSC) 
The DSC pattern was analyzed by METTLER TOLEDO (Star SW 920). 
Pure drug and physical mixture of drug and excipients were heated 
in a crimped aluminum pan with a pierced lid at a scanning rate of 
10 °C/min in an atmosphere of nitrogen flow (40 ml/min) in the 
range of 30-350 °C. 
Fourier transform infrared spectroscopy (FTIR) 
The FT-IR spectrum of pure drug and physical mixture of drug and 
excipients were recorded on FTIR spectrophotometer (FTIR 8400S, 
Shimadzu) using KBr powder press technique. The instrument was 
operated under dry air purge with the resolution of cm-1 over the 
region 4000-400 cm-1. 
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Formulation of orally disintegrating tablets 
Preliminary batches for selection of a concentration of 
sublimating agent 
Camphor was selected as a sublimating agent for this work. Batches 
with various concentrations of camphor were taken to determine 
the optimized concentration of camphor. The composition for 
preliminary batches was mention in table 1. 
Composition for factorial batches 
The orally disintegrating tablet was prepared by the sublimation 
technique. Drug and all other excipients without lubricant were 
passed through mesh no 60. Care should be taken for proper 
mixing of drug and excipient. The obtained mixture of drug and 
excipients were lubricated with talc and magnesium stearate. 
The resultant mixtures were directly compressible into a tablet 
using 8 mm round flat punches using 16 stationary tableting 
machine. After compression tablets were subjected to 
sublimation, by put in a hot air oven at 60 °C for 60 min. to 
generate porous structure in tablets. The composition of each 
tablet was mention in table 2 [18-19]. 
32 Full factorial designs 
A 32 full factorial design was examined to study the combined effect 
of two formulation variables-the amount of Crospovidone (X1) and 
Croscarmellose sodium (X2) at three-level (low, medium, high) and 
composition mention in (table 3). Disintegration time (DT) and % 
friability were taken as dependent variables. 
 
Table 1: Composition of sublimating agent 
Ingredients (mg) N1 N2 N3 
Chlorpheneramine maleate 4 4 4 
Crospovidone 5 5 5 
Croscarmellose sodium 5 5 5 
Camphor 10 15 20 
Saccharin sodium 2 2 2 
Orange flavor 2 2 2 
Magnesium stearate 3 3 3 
Talc 3 3 3 
Mannitol 116 111 106 
Total 150 150 150 
Disintegration time 42 sec 39 sec 34 sec 
(Total weight of each tablet is 150 mg) 
 
Table 2: Composition of various batches of chlorpheneramine maleate tablet as per 32 full factorial designs 
Ingredients (mg) A1 A2 A3 A4 A5 A6 A7 A8 A9 
Chlorpheneramine maleate 4 4 4 4 4 4 4 4 4 
Crospovidone 5 5 5 10 10 10 15 15 15 
Croscarmellose sodium 5 10 15 5 10 15 5 10 15 
Camphor 20 20 20 20 20 20 20 20 20 
Saccharin sodium 2 2 2 2 2 2 2 2 2 
Orange flavor 2 2 2 2 2 2 2 2 2 
Magnesium stearate 3 3 3 3 3 3 3 3 3 
Talc 3 3 3 3 3 3 3 3 3 
Mannitol 106 101 96 101 96 91 96 91 86 
Total 150 150 150 150 150 150 150 150 150 
(Total weight of each tablet is 150 mg) mg-milligram 
 
Table 3: Amount of variables in factorial designs 
Coded value Actual values 
 X1: CP X2: CCS 
-1 5 5 
0 10 10 
+1 15 15 
(X1–Crospovidone, X2–Croscarmellose sodium) 
 
Evaluation of prepared orally disintegrating tablet 
Precompression parameters 
Bulk density 
Bulk density was determined by pouring the blend into a graduated 
cylinder. it is obtained by dividing the weight of the sample in grams 
by final volume [20]. 






The measuring cylinder containing a known mass of blend was 
tapped for 100 times [20]. 






Carr’s index was measured by the following formula [20]. 
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Carr′s index % =  
Tapped density − bulk density
Tapped density
 × 100 
Hausner ratio 
Hausner ratio was determined from the ratio tapped density to bulk 
density using the following formula [20]. 




Angle of repose 
The angle of repose was determined by using the fixed funnel 
method. The blend was poured through a funnel that can be raised 
vertically until a maximum cone height (h) was obtained. The radius 
of the heap (r) was measured and the angle of repose was 
determined by using formula [20]. 




Post compression parameters 
Hardness 
The hardness of tablets is an important factor in the development of 
ODTs as excessive crushing strength of tablets reduces 
disintegration time. The hardness of the tablet measured by Digital 
hardness tester and expressed in kg/cm2 [21]. 
Thickness 
Thickness was measured by using Vernier calipers and expressed in 
mm [21]. 
Friability 
Friability is the measurement of tablet strength. Roche friabilator 
(FT1020, Labindia) was used for testing the friability using the 
following procedure. 10 tablets were weighed accurately and placed 
in the tumbling apparatus that revolves at 25 rpm for 4 min, 
dropping the tablets through a distance of six inches with each 
revolution. After 100 revolutions, the tablets were weighed and the 
% friability was calculated measured using the formula [22].  
Friability =  
Initial weight of tablets − Final weight of tablets
Initial weight of tablets
 × 100 
Wetting time 
A petri-dish containing 6 ml of distilled water was taken and tissue paper 
folded twice was placed in it. A tablet having amaranth powder on the 
upper surface was placed on the filter paper. The time required to 
develop a red color on the surface of the tablet was recorded [23]. 
Water absorption ratio 
A pre-weighed tablet (Wa) was placed in a petri dish the same as 
procedure describes in wetting time. After the tablet was absorbed 
water completely it was removed and weight was noted (Wb). Water 
absorption ratio R calculated as [24]. 
R =  
W+ & W,
W,
 × 100 
Weight variation 
Weight variation test was performed for twenty tablets from each 
batch using electric balance and the average value was calculated [25]. 
Disintegration time 
In vitro disintegration time was measured by using the 
disintegration test apparatus at 37 °C using distilled water. The time 
taken for complete disintegration of the tablet was recorded in 
second [25]. 
Drug content 
Ten tablets were weighed and made in fine powder, a quantity 
equivalent to 4 mg of Chlorpheneramine maleate was weighed and 
dissolved in a suitable quantity of pH 6.8. The Chlorpheneramine 
maleate content was determined by measuring absorbance at 264 
nm using UV-visible Spectrophotometer. The drug content was 
determined by using the standard calibration curve [23-24]. 
In vitro drug release study 
In vitro drug release of the tablet was carried out using USP 
dissolution testing apparatus II (Paddle). The dissolution testing was 
carried out using 900 ml phosphate buffer pH 6.8, at 37 °C and 50 
rpm. A sample of 5 ml was withdrawn at 2, 4, 6, 8, 10 min. The 
sample was replaced with a fresh dissolution medium of the same 
quantity. The sample was analyzed at 264 nm by using UV-
spectrophotometer. The percentage of drug release was calculated 
using the equation obtained from the calibration curve [24-26]. 
 
 
Fig. 1: DSC of pure drug 
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Fig. 2: DSC of optimized formulation (A9) 
 
Scanning electron microscopy (SEM) 
Optimized formulation from the factorial study was analyzed for the 
porous nature of the tablet by using the SEM technique [23]. 
Stability study 
Stability studies were carried out on optimized formulation as per 
ICH specifications. The tablet was stored at 40±2 °C/75±5 % RH for 
the duration of three mo. After an interval of one mo, the sample was 
withdrawn and analyzed for organoleptic properties, hardness, and 
disintegration time [23-25]. 
RESULTS  
Characterization of drug and excipients 
Differential scanning calorimetry (DSC)  
Thermal analysis of pure drug and optimized formulation (A9) was 
carried out by using Stare SW920. The DSC thermogram of the pure 
drug showed a sharp endothermic peak at 135 °C which indicates the 
crystalline nature of the drug. Optimized formulation showed that 
there was no interaction between drug and excipients (fig. 1 and fig. 2) 
Fourier transform infrared spectroscopy (FTIR) 
IR spectra showed that there was no interaction between drug and 
excipients (fig. 3 and fig. 4). 
Precompression parameters 
Bulk density, tapped density, compressibility index, Hausner's ratio, 
angle of repose of all batches were summarized in (table 4). The 
result obtained for all batches was concluded that good flow 
properties for tablet blends. 
Post compression parameters 
All results were summarized in (table 5 and 6). 
Hardness- Hardness of tablet was found to be in the range 3.1 to 3.2 
kg/cm2 indicating good strength of tablets to withstand stress 
during transportation. 
Thickness- Thickness of tablet was found a uniform for all batches, 
3.22 to 3.25 mm. 
Friability- % friability was found to be in range 0.51 to 0.70 % 
Wetting time-The wetting time was found to be in range 32±1.46 to 
42±1.23 s. 
Water absorption ratio-It was found between the ranges 
70.27±0.41 to 75.86±0.35 %. 
Weight variation- The prepared formulation comply weight 
variation test as per IP in the range 145±1.48 mg to 149±2.18 mg. 
 
 
Fig. 3: FTIR of pure drug 
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Fig. 4: FTIR of optimized formulation (A9) 
 
Table 4: Precompression parameters evaluations 
Batch no *Bulk density (g/ml) *Tapped density (g/ml) *Compressibility index (%) *Hausner’s ratio *Angle of repose ( °) 
A1 0.35±0.045 0.40±0.032 12.5±0.02 1.14±0.13 27.87±0.04 
A2 0.35±0.041 0.40±0.040 12.68±0.01 1.14±0.11 28.73±0.11 
A3 0.36±0.046 0.41±0.036 11.38±0.05 1.13±0.12 27.58±0.06 
A4 0.36±0.042 0.42±0.038 13.12±0.05 1.16±0.11 29.03±0.12 
A5 0.35±0.043 0.40±0.042 11.10±0.12 1.14±0.12 29.31±0.11 
A6 0.36±0.042 0.41±0.041 12.89±0.01 1.13±0.13 27.05±0.13 
A7 0.35±0.046 0.41±0.045 14.84±0.06 1.17±0.11 29.98±0.14 
A8 0.36±0.043 0.41±0.046 13.34±0.02 1.13±0.11 30.58±0.11 
A9 0.36±0.045 0.42±0.039 13.67±0.04 1.16±0.12 28.13±0.12 
(*all values are expressed as mean n=3,±SD: standard deviations) 
 
Table 5: Evaluation of all batches of chlorpheneramine maleate 








*Water absorption ratio (%) 
A1 3.2±0.1 3.22 0.70±0.11 42±1.23 73.79±2.28 
A2 3.3±0.11 3.23 0.68±0.13 45±1.45 71.23±1.15 
A3 3.1±0.21 3.23 0.62±0.11 41±0.24 72.60±1.23 
A4 3.2±0.2 3.22 0.64±0.06 40±0.62 70.00±1.48 
A5 3.1±0.1 3.22 0.62±0.02 42±1.12 70.94±0.28 
A6 3.3±0.23 3.23 0.60±0.15 40±1.86 74.48±0.56 
A7 3.4±0.12 3.22 0.59±0.11 36±0.25 70.27±0.27 
A8 3.2±0.1 3.25 0.58±0.03 38±0.72 72.29±0.41 
A9 3.2±0.1 3.23 0.51±0.07 32±1.46 75.86±0.35 
(*all values are expressed as mean n=3,±SD: standard deviations) 
 
Table 6: Evaluation of all batches of chlorpheneramine maleate 
Batch no *Weight variation (mg) *Disintegration time (s) Drug content (%) In vitro drug release (%) 
A1 146±2.36 39±1.20 97.52 92.76 
A2 145±2.45 40±1.25 97.59 93.72 
A3 149±2.18 36±2.48 98.55 95.78 
A4 148±1.25 34±1.59 97.54 96.42 
A5 145±1.48 31±2.16 97.5 97.58 
A6 147±1.36 33±0.98 102.50 98.67 
A7 145±2.69 30±0.56 96.63 99.45 
A8 146±2.48 28±1.27 102.50 99.51 
A9 146±2.45 26±0.36 98.75 99.77 
 (*all values are expressed as mean n=3,±SD: standard deviations), Disintegration time-Optimized formulation A (9) showed the least 
disintegration time 26 s., Drug content-Drug content of Optimized formulation A (9) was found to be 98.75 %., % drug release-Optimized 
formulation A (9) showed a 99.77 % drug release within 6 min. (fig. 5). 
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Fig. 5: % cumulative release of drug 
 
Factorial design 
Table 7: Formulation and disintegration time and percentage friability characteristics of factorial batches 
Batches code Variable level in coded form Disintegration time (s) % Friability 
X1 X2   
A1 -1 -1 39±1.20 0.70±0.11 
A2 -1 0 40±1.25 0.68±0.13 
A3 -1 +1 36±2.48 0.62±0.11 
A4 0 -1 34±1.59 0.64±0.06 
A5 0 0 31±2.16 0.62±0.02 
A6 0 +1 33±0.98 0.60±0.15 
A7 +1 -1 30±0.56 0.59±0.11 
A8 +1 0 28±1.27 0.58±0.03 
A9 +1 +1 26±0.36 0.51±0.07 
(X1–Crospovidone, X2–Croscarmellose sodium) 
 
The concentration of Crospovidone(X1) and Croscarmellose sodium 
(X2) were selected as an independent variable. A statistical model, 
Y  b. / b'X' / b1X1 / b'1X'X1 / b''X'
1 / b'1X1
1, 
Incorporating interactive and polynomial terms was used to evaluate 
response. The data obtained after the evaluation of factorial batches 
were analyzed using commercially available software minitab®18. 
The disintegration time and percentage friability show wide variation 
for nine batches (A1 to A9), i. e (26-39 s, 0.51-0.70 %). The data clearly 
confirmed that disintegration time and percentage friability are 
strongly depended on independent variables. 
Disintegration time 
The polynomial equation was found to be- 
Y (disintegration time) = 45.83  1.000X'  0.3000X1………. 
equation …….. 1 
The–ve sign for X1 and X2 indicates that as the concentration of 
super disintegrant increases disintegration time decreases. The 
surface response plot shows the effect of Crospovidone and 
Croscarmellose sodium (fig. 6). The model was considered as 
significant with (p<0.05) value 0.002. 
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% friability 
The polynomial equation was found to be- 
Y (% friability) = 0.7467 − 0.011167X' + 0.00300X1……. equation 2 
The–ve sign for X1 indicates that as the concentration of super 
disintegrant increases, friability decreases. The surface response 
plot shows the effect of Crospovidone and Croscarmellose sodium 
(fig. 7). Model is considered significant with (p<0.05) value 0.029. 
 
 
Fig. 7: Surface plot for % friability 
 
Table 8: Stability data 
Parameters Initial After 3 mo stability study 
Appearance White  White 
Disintegration time 26 s 24 s 
Hardness  3.2 kg/cm2 3.1 kg/cm2 
 
 
Fig. 8: SEM of optimized formulation A (9) 
 
Stability study 
Optimized formulation A (9) was kept for the stability test for three 
mo. After three mo, it was seen that formulation was stable. Results 
were summarized in (table 8). 
SEM analysis 
SEM study revealed the formation of a porous structure within the 
tablet. Optimized formulation A (9) was analyzed for SEM and 
Shown in fig. 8 
DISCUSSION 
Camphor was selected as a sublimating agent in this present work. 
To determine the optimized concentration of camphor, preliminary 
batches were carried out with different concentrations of the 
sublimating agent. The disintegration time values for all batches 
were mentioned in table 1. Batch N (3) with 20 mg camphor showed 
the least disintegration time as compared to others due to the 
development of the higher porous structure. So, a higher 
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Mannitol was used as diluent due to its negative heat of dissolution, 
good mouth feels. Microcrystalline cellulose was dropped out from 
study because sometimes it causes grittiness in the mouth. 
Crospovidone and Croscarmellose sodium were used as super 
disintegrants. They showed capillary action of a mechanism. 
Saccharin sodium and the orange flavor were used as taste-masking 
agent. 
DSC of pure drug sample showed a sharp endothermic peak at 135 
°C which was near to its melting point range (130–135 °C). The 
nature of the peak showed the purity of the drug sample. DSC of 
optimized formulation A (9) showed that there were no interactions 
between drug and excipients. The FTIR of pure drug and an 
optimized batch A (9) showed all peak ranges are uniform. NH 
stretch (primary amine) of pure drug obtained at 3225.95 cm-1 and 
that of an optimized batch showed at 3271.38 cm-1. CH stretch 
(alkane) of the pure drug showed a peak at 3009.05 cm-1 and that of 
optimized formulation showed at 2931.90 cm-1. C-N (aromatic 
nuclei) showed a peak at 1273.06 cm-1 for pure drug and for 
optimized formulation at 1365.65 cm-1. DSC and FTIR study showed 
that drug and excipients are compatible with each other. 
Tablet blend was analyzed for bulk density, tapped density, 
compressibility index, Hausner's ratio, angle of repose. All 
parameters for batch A (1) to A (9) were within the limit and 
showed good flow property. Hardness and thickness for all 
formulation were found to be uniform and within the range that 
showed good mechanical strength for tablets. % friability for all 
formulation was found to be within the IP limit (<1 %) indicating its 
good mechanical strength. A (9) formulation showed less % friability 
as compared to other formulations due to the higher concentration 
of Crospovidone which was essential for making less friable tablets. 
Lower wetting time gives faster disintegration in A (9) as compared 
to others. A Higher absorption ratio of an optimized batch is directly 
proportional to its dissolution rate. 
All batches were passed weight variation test as per IP limit. The 
permissible limit was ±7.5 %. 
Batch A (9) showed the least disintegration time with 10% 
Crospovidone and 10% Croscarmellose sodium as compared to 
other formulations. The Higher concentration of super disintegrants 
was essential for the rapid disintegration of the tablet. Tablet 
prepared by direct compression technique showed disintegration 
time at 3 min [12]. So, as per the above result sublimation technique 
was better than the direct compression method. Drug content for all 
batches was within the limit 95.0 to 105.0 % meeting to the IP 2010 
specification limit of chlorpheneramine maleate. Optimized 
formulation A (9) showed higher drug release 99.77% within 6 min. 
Tablet prepared by the direct compression method showed drug 
release 94.95 % within 45 min [12]. It showed that the sublimation 
technique gives faster release than direct compression. The 
concentration of Crospovidone and Croscarmellose sodium was 
selected as an independent variable and disintegration time, % 
friability was selected as the dependent variable in 32 factorial 
studies. The result showed that the dependent variables strongly 
depend on independent variables.  
As the concentration of super disintegrant increases, disintegration 
time and and % friability decreases. The Model considered as 
significant. The stability study showed that there were no major 
changes made on tablets. SEM study showed that sublimation of 
camphor formed the porous structure in the tablet matrix which was 
essential for the rapid disintegration of the tablet. 
CONCLUSION 
The current study revealed the successful formation of the orally 
disintegrating tablet of chlorpheneramine maleate by sublimation 
method to avoid the first-pass metabolism of the drug and improves 
patient compliance. Batch A (9) showed an optimized result for drug 
release and disintegration time. It was confirmed that as the 
concentration of super disintegrants increase, disintegration time 
decreases. The factorial study revealed that disintegration time and 
% friability depends on independent variables. 
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